ANETUMABUM RAVTANSINUM

Látka

ANETUMAB RAVTANSIN

ANETUMAB RAVTANSINE

Informace o látce

INN název: ANETUMABUM RAVTANSINUM
Český název: ANETUMAB RAVTANSIN
Anglický název: ANETUMAB RAVTANSINE
Kód látky: 20166

Synonyma

CAS 1375258-01-7(CA)ANETUMAB RAVTANSINE(INNE)ANÉTUMAB RAVTANSINE(INNF)ANETUMAB RAVTANSINA

Přípravky (0)

Žádné přípravky nenalezeny.

(INNS)

ANETUMAB RAVTANSIN(INND)

ANETUMAB RAVTANSIN(INNC)

IMMUNOGLOBULIN G1-LAMBDA2, ANTI-[HOMO SAPIENS MSLN (MESOTHELIN, PRE-PRO-MEGAKARYOCYTE-POTENTIATING FACTOR, MEGAKARYOCYTE POTENTIATING FACTOR, MPF, CAK1)], H. SAPIENS MONOCL. ANTIBODY CONJUG. TO MAYTANSINOID DM4; GAMMA1 HEAVY CHAIN (1-450) [HOMO SAPIENS VH (IGHV5-51*01 (94.90%) -(IGHD)-IGHJ4*01) [8.8.13] (1-120) -IGHG1*01 (CH1 (121- 218), HINGE (219-233), CH2 (234-343), CH3 (344-448), CHS (449- 450)) (121-450)], (223-216')-DISULFIDE WITH LAMBDA LIGHT CHAIN (1'- 217') [HOMO SAPIENS V-LAMBDA (IGLV2-14*01 (95.60%) -IGLJ2*01) [9.3.11] (1'-111') -IGLC2*01 A43>G (155) (112'-217')]; DIMER (229- 229'':232-232'')-BISDISULFIDE; CONJUGATED, ON AN AVERAGE OF 3 LYSYL, TO MAYTANSINOID DM4 [N^2'-DEACETYL-N^2'-(4-MERCAPTO-4-METHYL- 1-OXOPENTYL)-MAYTANSINE] VIA THE REDUCIBLE SPDB LINKER [N-SUCCINIMIDYL 4-(2-PYRIDYLDITHIO)BUTANOATE], RECOMMENDED INN: LIST 71(WHO)

ANETUMABUM RAVTANSINUM(INN)